Tara Lynn Kieffer - Net Worth and Insider Trading
Tara Lynn Kieffer Net Worth
The estimated net worth of Tara Lynn Kieffer is at least $430,135 dollars as of 2024-08-27. Tara Lynn Kieffer is the Chief Product Strategy Officer of Enanta Pharmaceuticals Inc and owns about 32,341 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $430,135. Details can be seen in Tara Lynn Kieffer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tara Lynn Kieffer has not made any transactions after 2024-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tara Lynn Kieffer
Tara Lynn Kieffer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tara Lynn Kieffer owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Tara Lynn Kieffer’s form 4 insider trades.
Insider Ownership Summary of Tara Lynn Kieffer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ENTA | Enanta Pharmaceuticals Inc | 2024-06-17 | Sr. VP & New Product Dev. |
Tara Lynn Kieffer Latest Holdings Summary
Tara Lynn Kieffer currently owns a total of 1 stock. Tara Lynn Kieffer owns 32,341 shares of Enanta Pharmaceuticals Inc (ENTA) as of June 17, 2024, with a value of $430,135.
Latest Holdings of Tara Lynn Kieffer
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ENTA | Enanta Pharmaceuticals Inc | 2024-06-17 | 32,341 | 13.30 | 430,135 |
Holding Weightings of Tara Lynn Kieffer
Tara Lynn Kieffer Form 4 Trading Tracker
According to the SEC Form 4 filings, Tara Lynn Kieffer has made a total of 2 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 7,266 shares on June 17, 2024, which brought Tara Lynn Kieffer around $89,590.
Insider Trading History of Tara Lynn Kieffer
- 1
Tara Lynn Kieffer Trading Performance
Tara Lynn Kieffer Ownership Network
Ownership Network List of Tara Lynn Kieffer
Ownership Network Relation of Tara Lynn Kieffer
Tara Lynn Kieffer Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Tara Lynn Kieffer is the Sr. VP & New Product Dev. of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & Business Dev. Brendan Luu , and Chief Scientific Officer Yat Sun Or .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Tara Lynn Kieffer made 2 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 9,391. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 35,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .
In summary, during the past 3 months, insiders sold 19,211 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 19,211 shares. During the past 18 months, 106,033 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 106,033 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Tara Lynn Kieffer Mailing Address
Above is the net worth, insider trading, and ownership report for Tara Lynn Kieffer. You might contact Tara Lynn Kieffer via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.